[Experimental research on the toxicity of pharmapentoxifylline (II)].
The results from morphological studies on liver, lung, heart, spleen, intestine, brain, skin, testes (ovaries), obtained in the end of the first and third month of animals, treated with pharmapentoxiphyline (PP), are described. The experiments were carried out on 312 white rats (male and female), divided into 2 series: I series--oral usage of the preparation in doses of 100, 300 and 6 mg/kg, II series--intraperitoneal administration in doses of 30, 75 and 150 mg/kg. It was established that PP, administered for a period of 3 months orally in a dose of 100 mg/kg and intraperitoneally in a dose of 30 mg/kg did not induced changes in the structure of all examined organs. Slight dystrophic changes in liver, lung and spleen occurred in the end of the third month under the influence of an oral dose of 300 mg/kg and an intraperitoneal dose of 75 mg/kg. The obtained results are discussed in connection with the pharmacological action of drug-peripheral vasodilatator.
Koleva
M
M
Donchev
N
N
Borov
B
B
Dzharova
V
V
D000284:Administration, Oral; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D007274:Injections, Intraperitoneal; D008297:Male; D010431:Pentoxifylline / Q000633:toxicity*; D011041:Poisoning / Q000473:pathology; D051381:Rats; D013997:Time Factors
D010431:Pentoxifylline
Eksperimentalni prouchvaniia vŭrkhu toksichnostta na farmapentoksifilin (II sŭobshtenie).